HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Jaffe, R. C Articles by Fazleabas, A. T Search for Related Content PubMed PubMed Citation Articles by Jaffe, R. C Articles by Fazleabas, A. T

¹ Departments of Physiology and Biophysics,
² Epidemiology and Biostatistics and
³ Obstetrics and Gynecology, University of Illinois at Chicago, 835 South Wolcott, Chicago, Illinois 60612, USA

(Requests for offprints should be addressed to R C Jaffe; Email: rcjaffe{at}uic.edu)

During the late luteal phase of the menstrual cycle and early pregnancy, the major secretory product of the uterine glandular epithelial cells in humans and non-human primates is glycodelin. Previous studies using Ishikawa cells, a human endometrial cell line, have shown that a chimeric plasmid containing the baboon glycodelin promoter responds to progestins but the response is modest compared with the induction of glycodelin seen in vivo and in gene array analysis. A recent report indicating that the histone deacetylase inhibitor trichostatin A (TSA) promoted glycodelin expression prompted us to examine its mechanism of action. In Ishikawa cells transfected with the baboon glycodelin promoter, TSA and the synthetic progestin medroxyprogesterone acetate both stimulated expression of the reporter and the combined treatment produced a synergistic effect. The effect of TSA and progestin was absent when the same promoter constructs were transfected into COS-1 cells, a kidney cell line, and a TSA effect but no progestin effect was observed in T47D cells, a mammary cell line. Through deletion analysis, the TSA action was localized to the –67/–52 region of the baboon glycodelin promoter, a region which contains the proximal Sp1 site. Deletions of this same region had no effect on progestin responsiveness. Our findings indicate that at least two regions of the glycodelin promoter are important for the normal induction of glycodelin expression. Non-target cells may lack factors which act on the response elements resulting in the restriction of expression to the appropriate target tissue.

This article has been cited by other articles:

				G. Weiss, L. T. Goldsmith, R. N. Taylor, D. Bellet, and H. S. Taylor Inflammation in Reproductive Disorders Reproductive Sciences, February 1, 2009; 16(2): 216 - 229. [Abstract] [PDF]

				M Seppala, H Koistinen, R Koistinen, L Hautala, P C Chiu, and W S Yeung Glycodelin in reproductive endocrinology and hormone-related cancer Eur. J. Endocrinol., February 1, 2009; 160(2): 121 - 133. [Abstract] [Full Text] [PDF]

				M. K. Tee, J.-L. Vigne, J. Yu, and R. N. Taylor Natural and recombinant human glycodelin activate a proapoptotic gene cascade in monocyte cells J. Leukoc. Biol., April 1, 2008; 83(4): 843 - 852. [Abstract] [Full Text] [PDF]

				K. Ohta, T. Maruyama, H. Uchida, M. Ono, T. Nagashima, T. Arase, T. Kajitani, H. Oda, M. Morita, and Y. Yoshimura Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone-induced regulator for endometrial epithelial cell growth Mol. Hum. Reprod., January 1, 2008; 14(1): 17 - 22. [Abstract] [Full Text] [PDF]